HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Watkins, P. B. Articles by Guzelian, P. S. Search for Related Content PubMed PubMed Citation Articles by Watkins, P. B. Articles by Guzelian, P. S. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 261, Issue 14, 6264-6271, 05, 1986

Macrolide antibiotics inhibit the degradation of the glucocorticoid- responsive cytochrome P-450p in rat hepatocytes in vivo and in primary monolayer culture

PB Watkins, SA Wrighton, EG Schuetz, P Maurel and PS Guzelian

Treatment of rats with macrolide antibiotics such as triacetyloleandomycin (TAO) dramatically increases the hepatic concentration of a cytochrome P-450 indistinguishable from P-450p, the major liver cytochrome induced by glucocorticoids such as dexamethasone (Wrighton, S. A., Maurel, P., Schuetz, E. G., Watkins, P. B., Young, B., and Guzelian, P. S. (1985) Biochemistry 24, 2171-2178). To investigate the mechanism of induction of P-450p, we treated rats for 4 days with these agents and found that dexamethasone and TAO induced the synthesis of P-450p at least 70- and 35-fold over control values, respectively, as estimated from measurements of P-450p mRNA translatable in a cell-free system. However, the accumulation of P-450p holocytochrome (measured as TAO-metabolite spectral complex) or P-450p protein (measured by quantitative immunoblotting) increased at least 150-fold by TAO but only 32-fold by dexamethasone. The possibility that TAO decreases the degradation of P-450p was supported by the observation that administration of TAO to dexamethasone-treated rats labeled with NaH[14C]O3 and [3H]-delta-aminolevulinic acid retarded the decay of radioactive immunoprecipitable P-450p protein (t1/2 = 60 versus 14 h) and heme (t1/2 = 73 versus 10 h). To confirm these results, P-450p protein synthesis was measured as radioactivity incorporated into immunoprecipitable P-450p in primary monolayer cultures of adult rat hepatocytes incubated with [3H]leucine. Dexamethasone treatment of the cultures stimulated P-450p synthesis by at least 30-fold whereas macrolides were without effect. However, macrolide antibiotics but not dexamethasone inhibited the disappearance of radiolabeled P-450p from cultured hepatocytes similar to the results obtained in vivo. We conclude that macrolide antibiotics induce P-450p, the most rapidly turning over cytochrome yet reported, by stimulating its synthesis indirectly and by blocking its degradation, significantly.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. C. Zangar, N. Bollinger, S. Verma, N. J. Karin, and Y. Lu The Nuclear Factor-{kappa}B Pathway Regulates Cytochrome P450 3A4 Protein Stability Mol. Pharmacol., June 1, 2008; 73(6): 1652 - 1658. [Abstract] [Full Text] [PDF]

				M. Liao, V. G. Zgoda, B. P. Murray, and M. A. Correia Vacuolar Degradation of Rat Liver CYP2B1 in Saccharomyces cerevisiae: Further Validation of the Yeast Model and Structural Implications for the Degradation of Mammalian Endoplasmic Reticulum P450 Proteins Mol. Pharmacol., May 1, 2005; 67(5): 1460 - 1469. [Abstract] [Full Text] [PDF]

				R. C. Zangar, T. A. Kocarek, S. Shen, N. Bollinger, M. S. Dahn, and D. W. Lee Suppression of Cytochrome P450 3A Protein Levels by Proteasome Inhibitors J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 872 - 879. [Abstract] [Full Text] [PDF]

				Y. Osawa, E. R. Lowe, A. C. Everett, A. Y. Dunbar, and S. S. Billecke Proteolytic Degradation of Nitric Oxide Synthase: Effect of Inhibitors and Role of hsp90-Based Chaperones J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 493 - 497. [Abstract] [Full Text] [PDF]

				M. A. Sarkar, V. Vadlamuri, S. Ghosh, and D. D. Glover Expression and Cyclic Variability of CYP3A4 and CYP3A7 Isoforms in Human Endometrium and Cervix During the Menstrual Cycle Drug Metab. Dispos., January 1, 2003; 31(1): 1 - 6. [Abstract] [Full Text] [PDF]

				R. C. Zangar, A. L. Kimzey, J. R. Okita, D. S. Wunschel, R. J. Edwards, H. Kim, and R. T. Okita Cytochrome P450 3A Conjugation to Ubiquitin in a Process Distinct from Classical Ubiquitination Pathway Mol. Pharmacol., April 1, 2002; 61(4): 892 - 904. [Abstract] [Full Text] [PDF]

				W. El-Sankary, G. G. Gibson, A. Ayrton, and N. Plant Use of a Reporter Gene Assay to Predict and Rank the Potency and Efficacy of CYP3A4 Inducers Drug Metab. Dispos., November 1, 2001; 29(11): 1499 - 1504. [Abstract] [Full Text] [PDF]

				T. Kerbusch, R. A. A. Mathot, H. J. Keizer, G. P. Kaijser, J. H. M. Schellens, and J. H. Beijnen Influence of Dose and Infusion Duration on Pharmacokinetics of Ifosfamide and Metabolites Drug Metab. Dispos., July 1, 2001; 29(7): 967 - 975. [Abstract] [Full Text] [PDF]

				N. Ledirac, G. de Sousa, F. Fontaine, C. Agouridas, J. Gugenheim, G. Lorenzon, and R. Rahmani Effects of Macrolide Antibiotics on CYP3A Expression in Human and Rat Hepatocytes: Interspecies Differences in Response to Troleandomycin Drug Metab. Dispos., April 13, 2001; 28(12): 1391 - 1393. [Abstract] [Full Text]

				V. Werlinder, M. Backlund, A. Zhukov, and M. Ingelman-Sundberg Transcriptional and Post-Translational Regulation of CYP1A1 by Primaquine J. Pharmacol. Exp. Ther., April 1, 2001; 297(1): 206 - 214. [Abstract] [Full Text]

				H. Kim, D. A. Putt, R. C. Zangar, C. R. Wolf, F. P. Guengerich, R. J. Edwards, P. F. Hollenberg, and R. F. Novak Differential Induction of Rat Hepatic Cytochromes P450 3A1, 3A2, 2B1, 2B2, and 2E1 in Response to Pyridine Treatment Drug Metab. Dispos., March 1, 2001; 29(3): 353 - 360. [Abstract] [Full Text]

				J.A. Williams Single nucleotide polymorphisms, metabolic activation and environmental carcinogenesis: why molecular epidemiologists should think about enzyme expression Carcinogenesis, February 1, 2001; 22(2): 209 - 214. [Abstract] [Full Text] [PDF]

				B. S. Mayhew, D. R. Jones, and S. D. Hall An In Vitro Model for Predicting In Vivo Inhibition of Cytochrome P450 3A4 by Metabolic Intermediate Complex Formation Drug Metab. Dispos., September 1, 2000; 28(9): 1031 - 1037. [Abstract] [Full Text]

				G. Inselmann, A. Volkmann, and H. T. Heidemann Comparison of the Effects of Liposomal Amphotericin B and Conventional Amphotericin B on Propafenone Metabolism and Hepatic Cytochrome P-450 in Rats Antimicrob. Agents Chemother., January 1, 2000; 44(1): 131 - 133. [Abstract] [Full Text]

				B. J. Roberts and B. J. Roberts Evidence of Proteasome-mediated Cytochrome P-450 Degradation J. Biol. Chem., April 11, 1997; 272(15): 9771 - 9778. [Abstract] [Full Text] [PDF]